<DOC>
	<DOC>NCT01032109</DOC>
	<brief_summary>The purpose of this study is to compare 12-month results of two single initial treatments—photodynamic therapy with verteporfin alone and this therapy combined with intravitreal bevacizumab—for neovascular age-related macular degeneration, not including patients with polypoidal choroidal vasculopathy who were presumed to have age-related macular degeneration.</brief_summary>
	<brief_title>Photodynamic Therapy Alone Versus Combined With Intravitreal Bevacizumab for Age-related Macular Degeneration</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>choroidal neovascularization caused by agerelated macula degeneration no previous treatment a followup at least 12 months a baseline visual acuity ranging from a letter score of 0 to 70 on the Early Treatment Diabetic Retinopathy Study chart choroidal neovascularization caused by other eye diseases ocular surgery within the past 3 mouths history of uveitis intraocular pressure higher than 25 mmHg, or glaucoma history of systemic or ocular thromboembolic events.</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>